The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 139.50
Bid: 138.00
Ask: 140.00
Change: 1.00 (0.72%)
Spread: 2.00 (1.449%)
Open: 140.00
High: 140.50
Low: 139.50
Prev. Close: 138.50
XAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Change

23 Feb 2024 10:30

RNS Number : 1814E
Xaar PLC
23 February 2024
 

23 February 2024

Xaar plc

Board Change

Xaar plc, ("the Company" or "Xaar"), a leading inkjet printing technology group, announces today the appointment of Stuart Widdowson to the Board as a Non-Executive Director effective from 27 February 2024.

Mr Widdowson is appointed as a representative of Odyssean Capital LLP ("Odyssean"), pursuant to a relationship agreement between the Company and Odyssean. The key terms are summarised in the notes below.

Mr Widdowson is the Managing Partner of Odyssean Capital, which he founded in 2017. From 2009 until 2017, he was lead fund manager of Strategic Equity Capital plc, which experienced a turnaround in its performance and rating during his tenure. He began his career as a strategy consultant undertaking commercial due diligence and strategy projects for private equity and corporate clients, before working for HgCapital, a leading private equity investor.

As at the last practicable date the total shareholding of funds managed by Odyssean Capital was 13,175,000 ordinary shares in the Company ("Ordinary Shares") representing approximately 16.6 per cent. of the Company's share capital. Additionally, Mr Widdowson beneficially owns 25,000 Ordinary Shares and the joint venture partner of Odyssean Capital, Harwood Capital, owns 1,050,000 Ordinary Shares.

Notes:

A summary of the key terms of the Relationship Agreement is as follows:

· Xaar has granted Odyssean the right to appoint Mr Widdowson to be a Director of the Company for appointment to the Board (the "Nominated Director") for so long as Odyssean has the right to exercise at least 10% or more of the Company's ordinary shares or voting rights attaching to the ordinary shares;

· Odyssean undertakes to, inter alia: (1) conduct all transactions and relationships with any member of Xaar's group on an arm's length basis; (2) not take any action which would have the effect of preventing Xaar or any member of Xaar's group from carrying on business independently of Odyssean or its associates; (3) not influence the day-to-day running of the Company (save through Mr Widdowson's role as the Nominated Director) and (4) not vote to prevent Xaar being managed in accordance with the principles of good governance set out in the UK Corporate Governance Code; and

· the Relationship Agreement will terminate (1) on the date upon which Odyssean ceases to hold at least 10% of the ordinary shares of the Company or the voting rights attaching to the ordinary shares of the Company; (2) on six months' notice written notice by either party at any time or immediately upon written notice in the event of a material breach of the Relationship Agreement; or (3) in the event that the Company's ordinary shares cease to be listed on the Official List or another recognised UK stock exchange.

Pursuant to Listing Rule 9.6.13, it is confirmed that Mr Widdowson was a director and shareholder of Durendal Limited, a fund management business, which was wound up in 2015. His shareholding was acquired by the majority shareholder and the cash was distributed to all shareholders before the company was voluntarily liquidated.

There is no additional information required to be disclosed pursuant to Listing Rule 9.6.13 in relation to the appointment of Stuart Widdowson to the Board.

Enquiries:

Xaar plc

+44 (0) 1223 423 663 

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

 

Teneo Communications

Giles Kernick

Olivia Lucas

+44 (0) 207 353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOATTMPTMTTTBFI
Date   Source Headline
17th Mar 20107:00 amRNSFinal Results
12th Mar 20109:00 amRNSHolding(s) in Company
4th Mar 20107:00 amRNSDirectorate Change
1st Mar 20107:00 amRNSNotice of Final Results
19th Feb 20109:00 amRNSHolding(s) in Company
21st Jan 20107:00 amRNSPeriod end trading update
26th Oct 200910:42 amRNSHolding(s) in Company
14th Oct 20097:00 amRNSInterim Management Statement
16th Sep 20093:19 pmRNSHolding(s) in Company
10th Sep 200911:18 amRNSHolding(s) in Company
2nd Sep 20099:59 amRNSHolding(s) in Company
19th Aug 20097:00 amRNSHalf Yearly Report & Results
11th Aug 20097:00 amRNSNotice of Half Yearly Report
15th Jul 20097:00 amRNSHalf year period-end trading update
5th Jun 20091:22 pmRNSHolding(s) in Company
2nd Jun 200911:26 amRNSHolding(s) in Company
2nd Jun 200911:24 amRNSHolding(s) in Company
5th May 20095:04 pmRNSHolding(s) in Company
29th Apr 20092:06 pmRNSResult of AGM
16th Apr 20093:23 pmRNSGrant of Options
16th Apr 20097:00 amRNSAnnual Information Update
16th Apr 20097:00 amRNSInterim Management Statement
8th Apr 20099:35 amRNSChange of Adviser
7th Apr 20094:47 pmRNSDirector/PDMR Shareholding
3rd Apr 20093:38 pmRNSDirector/PDMR Shareholding
1st Apr 20094:04 pmRNSDirector/PDMR Shareholding
1st Apr 20097:00 amRNSManufacturing rationalisation
26th Mar 20095:21 pmRNSDirector/PDMR Shareholding
25th Mar 200910:38 amRNSDirector/PDMR Shareholding
23rd Mar 20097:00 amRNSFinal Results
13th Mar 20094:40 pmRNSSecond Price Monitoring Extn
13th Mar 20094:35 pmRNSPrice Monitoring Extension
6th Mar 20099:00 amRNSHolding(s) in Company
4th Mar 20097:00 amRNSNotice of Final Results
24th Feb 20097:00 amRNSNew product launch
18th Feb 200912:15 pmRNSDirector/PDMR Shareholding
16th Jan 20093:45 pmRNSHolding(s) in Company
15th Jan 20097:00 amRNSFull Year Trading Update
14th Jan 20093:00 pmRNSHolding(s) in Company
7th Jan 20094:15 pmRNSHolding(s) in Company
7th Jan 20099:00 amRNSHolding(s) in Company
23rd Dec 20083:57 pmRNSHolding(s) in Company
16th Dec 20084:40 pmRNSSecond Price Monitoring Extn
16th Dec 20084:35 pmRNSPrice Monitoring Extension
1st Dec 20083:10 pmRNSDirector/PDMR Shareholding
28th Nov 20089:00 amRNSDirector/PDMR Shareholding
26th Nov 20087:00 amRNSTrading Update
24th Nov 20084:40 pmRNSPrice Monitoring Extension
12th Nov 20084:05 pmRNSDirector/PDMR Shareholding Replacement
12th Nov 20083:03 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.